These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 7093587

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of the stimulant activities of oxotremorine analogues on the frog rectus abdominis and the guinea pig ileum.
    Ringdahl B.
    Eur J Pharmacol; 1984 Mar 23; 99(2-3):177-84. PubMed ID: 6234180
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterisation of the enantiomers of BM-5, a muscarinic partial agonist with opposed enantioselectivity between affinity and efficacy.
    Sundquist S, Modiri AR, Nilsson BM, Hacksell U, Gillberg PG, Nilvebrant L.
    Pharmacol Toxicol; 2000 Jan 23; 86(1):44-50. PubMed ID: 10720106
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationship between the contractile responses and their coupling second messenger systems for muscarinic drugs in the guinea-pig ileal longitudinal muscle.
    Konno F, Takayanagi I.
    Arch Int Pharmacodyn Ther; 1989 Jan 23; 301():15-29. PubMed ID: 2624513
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structural requirements for affinity and efficacy of N-(4-amino-2-butynyl)succinimides at muscarinic receptors in the guinea-pig ileum and urinary bladder.
    Ringdahl B.
    Eur J Pharmacol; 1987 Aug 04; 140(1):13-23. PubMed ID: 3622621
    [Abstract] [Full Text] [Related]

  • 17. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.
    Sauerberg P, Kindtler JW, Nielsen L, Sheardown MJ, Honoré T.
    J Med Chem; 1991 Feb 04; 34(2):687-92. PubMed ID: 1995893
    [Abstract] [Full Text] [Related]

  • 18. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B, Roch M, Jenden DJ.
    J Pharmacol Exp Ther; 1987 Aug 04; 242(2):464-71. PubMed ID: 3612545
    [Abstract] [Full Text] [Related]

  • 19. Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum.
    Kilbinger H, Halim S, Lambrecht G, Weiler W, Wessler I.
    Eur J Pharmacol; 1984 Aug 17; 103(3-4):313-20. PubMed ID: 6489444
    [Abstract] [Full Text] [Related]

  • 20. Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Nilsson BM, Ringdahl B, Hacksell U.
    J Med Chem; 1988 Mar 17; 31(3):577-82. PubMed ID: 3346873
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.